A recent scandal involving top doctors at a leading Chinese hospital has stirred public anger and raised serious questions about medical training and fairness in China’s healthcare system.
Hospital gossip erupted into a major controversy after a letter surfaced accusing surgeon Xiao Fei of cheating on his wife with junior doctor Dong Xiying. More shocking was the claim that Xiao left an anaesthetised patient unattended during surgery to confront a colleague criticizing Dong.
The China-Japan Friendship Hospital confirmed the accusations and announced Xiao’s dismissal on April 27. But public outrage shifted to Dong, whose unconventional medical background sparked widespread debate.
Unlike the typical 10-year path to becoming a doctor in China, Dong entered medicine through an experimental “4+4” program at Peking Union Medical College. This US-style program allows graduates from non-medical fields to earn a Doctor of Medicine degree and complete a shortened residency in just four years.
Introduced in 2018, the program aimed to attract diverse talent and break traditional barriers. Yet, after the scandal, doubts grew about whether this shorter training is enough. A doctor told Yicai news, “Medicine needs experience. Talent alone cannot solve real clinical problems.”
Public anger also reflects frustration with nepotism, which many believe is widespread in Chinese institutions. The idea that some may reach top hospitals through unfair advantages stings, especially as the economy slows and living standards stagnate.
An internet joke summed up this sentiment: a patient admits to pulling strings to get into the hospital. The surgeon replies, “I also got in through the back door,” and the assistant says, “Me too.” Then the virus asks, “Am I the only one who got here on merit?”
A decade ago, state media exposed “memo students” — children of officials admitted through special favors. If connections, not merit, determine who becomes a doctor, how can patients trust their safety?
This scandal adds to growing distrust in China’s healthcare. It follows concerns over the quality of cheap generic drugs bought in bulk by hospitals, which worry many about their effectiveness.
The healthcare system also struggles with overcrowded hospitals, long waits, and rushed appointments. Knowing a surgeon once studied economics does little to calm fears.
To rebuild trust, authorities must answer tough questions: Has the 4+4 program become a shortcut for the privileged? Will those involved be punished? How will medical qualifications be guaranteed? Without clear answers, public confidence is unlikely to return soon.
Related topics
